Data as of Apr 15
| -0.03 / -4.76%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +316.67% increase from the last price of 0.60.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.